Biotech Values

[Biowatch]

BPUR Conflicts of interest:

Someone who publishes a refereed article who has conflicts of interest that were later disclosed by the author should have their publication discounted entirely because they don't own BioPure stock, yet the doctor who runs a clinical trial using BioPure's product and publishes an article about the results should be congratulated for owning stock in the company?

Why don't you see a potential conflict of interest in the latter case?

In addition, using HemoPure in elective surgery in a controlled setting where advanced medical care is available at a moment's notice is substantially different from an acute care combat trauma setting, in my humble opinion. Consequently, the two situations are an apples and oranges comparison, and not meaningful.

Oddly enough, the major news story I recall about BioPure from 2007 was that their products turned up as performance enhancing drugs that one unwitting professional cyclist was asked to smuggle from the United States to Europe so another professional cyclist could presumably use it to boost their athletic performance without getting detected by standard tests.

Can you explain how any one outside of the company or doctors running clinical trials could provide athletes a product not approved by the FDA in this country? Especially, if you read the original story, large sums of money were spent to obtained this experimental product? #msg-21461633